FindTrial
Sign In

Effect of alepa in Rheumatoid arthritis

A CLINICAL STUDY TO EVALUATE EFFECT OF ALEPA IN THE MANANGEMENT OF RHEUMATOID ARTHRITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046114
Enrollment
20
Registered
2022-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M059- Rheumatoid arthritis with rheumatoid factor, unspecified

Interventions

None listed

Sponsors

Shri Dharmasthala Manjunatheshwara College of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling diagnostic criteria Patients who are fit for Alepa Chikitsa

Exclusion criteria

Exclusion criteria: All connective tissue disorders other than Rheumatoid Arthritis. Patients with any other systemic illness which will hamper treatment. Patients who are allergic to lepa.

Design outcomes

Primary

MeasureTime frame
Changes in inflammatory markers- ESR,CRP,RA,ASO Timepoint: 7 days—

Secondary

MeasureTime frame
Changes in inflammatory markers- ESR,CRP,RA,ASOTimepoint: 14 days—

Countries

India

Contacts

Public ContactDR PADMAKIRAN C

Shri Dharmasthala Manjunatheshwara college of Ayurveda and hospital

rao.drniranjan@gmail.com9448835203

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026